TMC207: Promising new drug for tuberculosis

Submitted by Bobby Ramakant (bobby) about 3 days ago

You like?
3
Or not?

Photo by prudencebrown121 Addition of the new drug, TMC207 to standard multidrug-resistant TB (MDR-TB) treatment regimens dramatically cuts the period from when patients start treatment to their sputum testing negative for TB. This new drug, TMC207 is being developed by a pharmaceutical research company, Tibotec, in collaboration with TB Alliance. Read more...

Addition of the new drug, TMC207 to standard multidrug-resistant TB (MDR-TB) treatment regimens dramatically cuts the period from when patients start treatment to their sputum testing negative for TB. This new drug, TMC207 is being developed by a pharmaceutical research company, Tibotec, in collaboration with TB Alliance.

Keywords: drug resistance extensively drug-resistant M/XDR-TB MDR-TB multi-drug resistant research TB TMC207 tuberculosis XDR-TB

Translate to: Translate to: English Translate to: Chinese Translate to: Arabic Translate to: French Translate to: German Translate to: Italian Translate to: Japanese Translate to: Korean Translate to: Portuguese Translate to: Russian Translate to: Spanish Translate to: Dutch Translate to: Hindi

West Africa 0 comments

  Some parts of London have TB incidence as high as high-burden TB countries

Submitted by Bobby Ramakant (bobby) about 3 days ago

 Stop-TB eCorrespondent: 22-30 June 2009

Submitted by Bobby Ramakant (bobby) about 3 days ago

 $196 billion; little proof UN health programs work

Submitted by Bobby Ramakant (bobby) about 3 days ago

 Going after chronic coughers to identify tuberculosis cases in Uganda

Submitted by Bobby Ramakant (bobby) about 3 days ago

 HIV prevention by Female Condom (FC)

Submitted by Kintu about 1 day ago

 Soaring global health funds not all wisely spent: studies

Submitted by Bobby Ramakant (bobby) about 3 days ago


Fatal error: Call to a member function finish() on a non-object in C:\websites\www.healthdev.net\site\index-full.php on line 95